BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2005
View Archived Issues
Neuroprotective antiinflammatory effects of the MLK inhibitor CEP-1347 shown in vitro and in vivo
Read More
The potent antitumor candidate XR-5944 displays a unique mechanism of action
Read More
AGS-PSCA: a candidate for clinical trials in prostate, pancreatic cancers
Read More
Transgenomic to provide additional nucleic acid products to Geron
Read More
Second phase review in Europe of Johnson & Johnson's acquisition of Guidant
Read More
Japan Tobacco and Torii pharma production facilities to merge
Read More
Exelixis submits IND for XL-820
Read More
Orphan drug designation for doxorubicin Transdrug in primary liver cancer
Read More
ThromboView update
Read More
Alizyme completes thorough cardiovascular safety trial of renzapride
Read More
Japanese approval of biopharmaceutical using GroPep's Cell Culture Products
Read More
Enrollment completed in diabetes study of Diamyd in children
Read More
Phase IIb study of Hamilton's HL-0812 supported by Series A financing
Read More
Myriad presents new data on anticancer drug candidates MPC-2130 and MPC-6827
Read More
Recent patents describe therapeutic agents for asthma
Read More
New immunomodulatory agents disclosed by General Atomics
Read More
Novel agents for urinary incontinence and renal disorders imparted in recent patents
Read More
New data on the safety profile of 17-AAG in patients with solid tumors
Read More
Discovery and preclinical profile of dual VEGFR-2/FGFR-1 kinase inhibitors
Read More
PU-H58, a highly potent and selective Hsp90 inhibitor
Read More
Promising results reported for SGN-40 in recurrent multiple myeloma
Read More
Preclinical evidence supports the use of CYC-202 in multiple myeloma
Read More
Update on lenalidomide in multiple myeloma
Read More
MP4 safe in human volunteers
Read More